Vertosa
Vertosa engineers proprietary nano- and micro-emulsion ingredients for cannabis and hemp infusion, supplying water-dispersible active cannabinoid emulsions to 150-plus beverage and edible brands across North America from a GMP-certified California facility.
- Company typePrivate
- Founded2018
- HeadquartersOakland, United States
- Headcount11–50
- GTM typeB2B
- OfferingHardware or Manufacturing
What Vertosa does
Vertosa Inc. is a privately held B2B ingredient supplier founded in 2018 by Dr. Harold Han (Chief Science Officer) and Ben Larson (CEO) in Walnut Creek, California. The company engineers proprietary nano- and micro-emulsion technologies for infusing cannabis and hemp-derived cannabinoids (THC, CBD, minor cannabinoids) into beverages and edible products. Its core offering is a pre-suspended aqueous liquid emulsion with sub-100nm to sub-micron droplet sizes, delivering approximately 15-minute onset, 3+ year shelf stability, and integration with multiple packaging formats (plastic, aluminum, glass, TetraPak). The technology platform includes versioned formulas (latest O4.1 with reduced bitterness), toll processing services that convert customer-supplied distillate, resin, or rosin into water-stable emulsions, and compatibility testing with leading can liner and packaging manufacturers.
Vertosa operates from a 10,000 sq ft GMP-certified facility and serves 150+ brands across 18 markets in the US and Canada via direct enterprise sales and a curated manufacturing/co-packing partner network. Customers range from startups (Spacestation, MXXN, The People's Ecosystem) to enterprise CPG accounts (Vita Coco, Pabst Labs, Boston Beer Co.'s Teapot, Tilray, Keef, Sweet Justice). The company supplements its product line with educational resources (Cannabis Beverage Manufacturing Handbook, pharmacokinetic studies, technical case studies) that reinforce thought leadership in the cannabis beverage category.
The business model is B2B ingredient sales with quote-based pricing disclosed only after a mutual NDA, a minimum order quantity of 250g of active cannabinoids, and revenue concentrated in emulsion ingredient sales supplemented by toll processing. Strategic capital includes a 2019 $6M funding round led by AFI Capital Partners and WelCan Capital, plus a 2024 strategic R&D partnership with Döhler supported by an investment from Döhler Ventures. Vertosa also maintains technology partnerships with Tetra Pak, Ball, Ardagh, and Gamer for aseptic processing and can liner compatibility testing, and Canadian manufacturing coverage via Taima Extracts.
Vertosa firmographics
Firmographics- Name
- Vertosa
- Legal name
- Vertosa Inc.
- Website
- https://vertosa.com
- Company type
- Private
- Founded year
- 2018
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- Vertosa engineers proprietary nano- and micro-emulsion ingredients for cannabis and hemp infusion, supplying water-dispersible active cannabinoid emulsions to 150-plus beverage and edible brands across North America from a GMP-certified California facility.
- Ownership category
- akta.pro rank
Vertosa industry classification
Industry- Product category
- Cannabis and Hemp Infusion Ingredients
- NAICS
- Medicinal and Botanical Manufacturing (325411)
- SIC
- Medicinal Chemicals & Botanical Products (2833)
- akta.pro primary industry
- Flavor Encapsulation & Delivery Systems (Spray-Dried, Emulsions, Encapsulates) (AFAJADAJ)
- akta.pro secondary industry
- Flavor Bases & Emulsions (Citrus oils, beverage emulsions, clouding agents) (AFAFAGAE)
Keywords
Where Vertosa is headquartered
LocationHeadquarters
- HQ city
- Oakland
- HQ country
- United States
- HQ region
- North America
Offices1 record
Markets served
Vertosa business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Personnel, Operations, Technology or R&D, Marketing or Sales, Infrastructure, Supply Chain
Revenue model
- Emulsion Ingredient Sales: Vertosa sells pre-suspended aqueous emulsion solutions as active ingredients to beverage and edible manufacturers. Products are sold in bulk as accurately dosed active ingredients, ranging from startups to large-scale product producers. Minimum order quantity is 250g of all active cannabinoids.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Other | Pay-as-you-go | B2B ingredient sales with quote-based pricing |
Go-to-market motion1 record
Distribution channels2 records
Marketing channels7 records
Vertosa product offering
Product offeringCore offering
Vertosa designs, formulates, and supplies custom nanoemulsion and microemulsion active ingredients that enable beverage and edible manufacturers to infuse cannabis and hemp-derived cannabinoids into their products. The company's pre-suspended aqueous emulsion solutions deliver water-dispersible, accurately dosed cannabinoid ingredients with sub-100nm droplet sizes, 15-minute onset, and 3+ year stability, sold in bulk (250g MOQ of active cannabinoids) to brands ranging from startups to large CPG manufacturers.
Product overview
Vertosa is an advanced infusion technology partner specializing in shelf-stable emulsified cannabinoids for beverages and edibles. The company offers liquid nanoemulsion solutions as its core product, enabling water-dispersible cannabinoid delivery with 15-minute onset times and 3+ year stability. The product portfolio centers on the Liquid Emulsion product line, including specialized formulas like O4.1, supplemented by toll processing services that transform customer-supplied cannabinoids into water-stable emulsions. Vertosa supports its products with extensive educational resources including the Cannabis Beverage Manufacturing Handbook, pharmacokinetic studies, and technical case studies covering various beverage processing methods.
Differentiator
Problem solved
Functional benefit
Products and services
- Liquid Emulsion Pre-suspended aqueous nanoemulsion solutions with sub-100nm to sub-micron droplet sizes that enable water-dispersible, accurately dosed cannabinoid ingredients with 15-minute onset and shelf stability up to one year refrigerated. Sold in bulk to beverage and edible manufacturers with a 250g MOQ of active cannabinoids. Used for infusing beverages, gummies, hard candies, and lubricants.
- O4.1 Emulsion Formula Advanced evolution of Vertosa's O4 emulsion formula featuring a significantly reduced bitterness profile that delivers a smoother taste experience, especially in higher-dose beverages, while maintaining exceptional stability and manufacturability for seamless integration into existing manufacturing processes.
- Toll Processing Services Vertosa transforms customer-supplied cannabinoids (distillate, resin, or rosin) into water-stable emulsion using its proprietary nanoemulsion process, enabling brands to outsource infusion processing without owning the underlying emulsion chemistry.
Quantifiable outcome
- 15-minute average onset time vs. hours for conventional oil-based edibles
- +3 more outcomes
Companies that use Vertosa
Customer profileNamed customers29 records
Segments4 records
Ideal customer profiles4 records
Vertosa technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature5 records
Vertosa partnerships and signals
Strategic signalPartnerships
Three partnerships are on record, tiered flagship and core.
- DöhlerflagshipStrategic research and development partnership for creating innovative life science beverages in cannabis and hemp sectors. Döhler provides natural ingredients and formulation support while Vertosa supplies infusion technologies. Supported by investment from Döhler Ventures. Collaboration aims to advance product standards and expand the market for cannabis and hemp beverages.
- Taima Extracts Inc.coreManufacturing partnership with Canadian-based Taima Extracts Inc. to provide co-packing and manufacturing capabilities for brands looking to enter the Canadian cannabis market.
- Tetra PakcorePartnership to evaluate what happens to cannabinoids when encountering aseptic processing and packaging. Vertosa partnered with Tetra Pak, an industry-leading food processing and packaging solutions company, to research compatibility and stability in aseptic processing.
Scale indicators3 records
Recent moves6 records
Expansion highlights7 records
Vertosa competitors and assessment
Company assessmentDirect peers
- Cure Pharmaceutical: Cure Pharmaceutical develops nanoemulsion-based drug delivery and cannabinoid-infused pharmaceutical and wellness products using its Curefilm and related platforms, overlapping Vertosa's emulsion science applied to cannabinoid therapeutics and consumer health applications.
- Verdure Sciences (LipiSperse): Verdure Sciences markets LipiSperse, a delivery technology that improves cannabinoid bioavailability and water dispersibility. It competes with Vertosa on the same core value proposition — turning oil-soluble cannabinoids into effective, consistent, water-friendly ingredients for brands.
- SōRSE Technology: SōRSE Technology develops proprietary emulsion technology specifically for cannabis and hemp beverage infusion, competing head-to-head with Vertosa across water-soluble cannabinoid delivery, beverage formulations, and brand partnerships with infused-beverage makers.
- NanoSphere Health Sciences: NanoSphere Health Sciences produces NanoSphere branded nano-liposomal delivery systems for cannabinoids and other actives, overlapping directly with Vertosa's nanoemulsion approach to bioavailability, fast onset, and stable infusion in consumer products.
Emerging players
- Abstrax Tech: Abstrax Tech develops cannabis-derived flavor and terpene ingredients used in infused beverages and edibles, intersecting with Vertosa's infusion value proposition on the taste, aroma, and formulation layer rather than at the emulsion technology layer.
- Demetrix: Demetrix uses synthetic biology and fermentation to produce rare cannabinoids, representing an emerging alternative supply path to plant-extracted cannabinoids used in emulsions. As a forward-looking competitor, it pressures Vertosa's cost curve and supply security for specific active ingredients.
Broad incumbents
- Canopy Growth: Canopy Growth is a leading global cannabis and CPG company with significant R&D and beverage interest (including Constellation-backed capabilities). It is a logical enterprise customer, competitor, or acquirer of infusion technology of the kind Vertosa provides.
- MediPharm Labs: MediPharm Labs is a GMP-certified cannabis extraction and contract manufacturer producing cannabinoid concentrates and formulated ingredients. Its ingredient-manufacturing footprint competes with Vertosa for brand customers looking for turnkey infused-beverage inputs.
- Nextleaf Solutions: Nextleaf Solutions develops proprietary cannabinoid extraction, distillation, and infusion technologies and holds patents around its processes. It is a broader cannabis-processing incumbent whose downstream infusion work overlaps with Vertosa's emulsion-based ingredient layer.
- Tilray Brands: Tilray is one of the largest global cannabis operators with branded infused beverages and supply-chain partnerships. As a customer and a potential vertically integrated competitor, it represents both a major revenue source for Vertosa and a long-term risk of in-housing emulsion capability.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat6 records
Key risks6 records
Key highlights7 records
Customer concentration
Vertosa social profiles
Digital presenceVertosa compliance and trust
Trust signalCompliance6 records
Vertosa financial estimates
Financial estimateRevenue estimate
Valuation estimate
Vertosa leadership team
Management profileNumber of profiles
Profiles6 records
Vertosa funding detail
Funding detailFunding overview
Funding rounds3 records
Investors7 records
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Vertosa M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Vertosa
What does Vertosa do?
Vertosa designs, formulates, and supplies custom nanoemulsion and microemulsion active ingredients that enable beverage and edible manufacturers to infuse cannabis and hemp-derived cannabinoids into their products. The company's pre-suspended aqueous emulsion solutions deliver water-dispersible, accurately dosed cannabinoid ingredients with sub-100nm droplet sizes, 15-minute onset, and 3+ year stability, sold in bulk (250g MOQ of active cannabinoids) to brands ranging from startups to large CPG manufacturers.
Is Vertosa a public or private company?
Vertosa is a private company. It is classified as venture growth investor backed and is currently operating.
When was Vertosa founded?
Vertosa was founded in 2018. It employs 11 to 50 people.
Where is Vertosa based?
Vertosa is headquartered in Oakland, United States, in the North America region.
How does Vertosa make money?
One revenue line is on record: emulsion Ingredient Sales.
Who are Vertosa's main competitors?
Direct peers on record are Cure Pharmaceutical, Verdure Sciences (LipiSperse), SōRSE Technology and NanoSphere Health Sciences. Emerging players are Abstrax Tech and Demetrix. Broad incumbents are Canopy Growth, MediPharm Labs, Nextleaf Solutions and Tilray Brands.
Does Vertosa have an API?
No public API is recorded for Vertosa.
What industry is Vertosa in?
Vertosa's product category is Cannabis and Hemp Infusion Ingredients. Its primary akta.pro industry code is AFAJADAJ, Flavor Encapsulation & Delivery Systems (Spray-Dried, Emulsions, Encapsulates), with a secondary code of AFAFAGAE, Flavor Bases & Emulsions (Citrus oils, beverage emulsions, clouding agents). Its NAICS code is 325411 and its SIC code is 2833.